Pricing Log in Create free account
Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue
−7.01%
EPS
−101.0%
Free cash flow
+561.9%
Total debt
−90.1%

Quarter to September 2026, against a year earlier

91.18 4.00 +4.59%
Market cap
$14.8B
P/E
97.3×
Fwd P/E
47.7×
Dividend yield
—
F-score
5/9
Altman Z
2.22
Beneish M
−2.07
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Solventum Corporation (SOLV) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Solventum Corporation (SOLV) trades at a EV/Sales of 2.4×. Over the past ten years it has ranged from 1.4× (March 2024) to 2.6× (February 2025); the current reading is higher than 72% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (4.23%)
FY2024 2.3× 36.26%
FY2023 1.7× 0.00%
FY2022 1.7× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.4× 11.22%
Jun 2026 2.2× 12.43%
Mar 2026 1.9× (10.13%)
Dec 2025 2.2× 11.65%
11 more quarters

Against its own ten years

Low 1.4× High 2.6×
Ten-year median 2.3×
Current reading's percentile 72

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. compare 1.7×
AVTR Avantor, Inc. compare 2.0×
BLCO Bausch + Lomb Corporation compare 2.2×
SOLV Solventum Corporation 2.4×
ALGN Align Technology, Inc. compare 2.4×
ATR AptarGroup, Inc. compare 2.6×
COO The Cooper Companies, Inc. compare 3.5×
WST West Pharmaceutical Services, Inc. compare 8.1×
RGEN Repligen Corporation compare 11.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SOLV